Subject | Visit 2 Quantitative SARS-CoV-2 Anti-Spike 1-RBD Antibody [U/mL] (N = 12) (Subjects who attended Visit 2 & 3) Reference range [< 0.8 U/mL] | Visit 3 Quantitative SARS-CoV-2 Anti-Spike 1-RBD Antibody [U/mL] (N = 26) (Total subjects who attended Visit 3) Reference range [< 0.8 U/mL] | T-cell Immunity Subset | Age (Visit 1) [Years] | Gender | Race | Ethnicity | CD4 count [cells/µL] | HIV Viral Load [copies/mL] | Body Mass Index [kg/m2] | Co-morbidities |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 430 | 68 | Male | White | Non-Hispanic | 553 | 0 | 22.38 | Heart Disease, Substance Use Disorder | ||
2 | 2500 | 1309 | 56 | Male | White | Non-Hispanic | 1123 | 0 | 29.09 | History of Cancer, Heart Disease, Lung Disease, Overweight | |
3 | 180 | 2500 | 50 | Male | White | Non-Hispanic | 407 | 0 | 25.04 | History of Cancer, Stroke, Advanced Lung Disease, Smoking history | |
4 | 2008 | 426 | T-Cell Subset | 63 | Male | Black | Non-Hispanic | 176 | 0 | 29.68 | |
5 | 2500 | 554 | 55 | Male | White | Hispanic | 1242 | 0 | 27.17 | Lung Disease, Substance Use Disorder | |
6 | 152 | 63 | Female | Black | Non-Hispanic | 374 | 0 | 20.66 | Smoking History | ||
7 | 1101 | 168 | 64 | Male | White | Non-Hispanic | 900 | 0 | 27.2 | Substance Use Disorder | |
8 | 48 | 61 | Male | White | Non-Hispanic | 801 | 0 | 28.86 | Chronic Kidney Disease | ||
9 | 879 | 349 | 61 | Female | Black | Non-Hispanic | 984 | 0 | 24.2 | ||
10 | 577 | 80 | Male | Black | Non-Hispanic | 718 | 0 | 27.25 | |||
11 | 2500 | 1299 | 55 | Female | White | Non-Hispanic | 359 | 0 | 26.63 | ||
12* | 29.3 | 66 | Male | Black | Non-Hispanic | 339 | 32.9 | 26.8 | Chronic Kidney Disease, Diabetes Mellitus, Heart Disease, Lung Disease | ||
13 | 2.14 | 20.6 | 66 | Female | Black | Non-Hispanic | 103 | 27.5 | 25.16 | Heart transplant recipient (on tacrolimus), Diabetes Mellitus, Heart Disease, Stroke | |
14 | 763 | 57 | Male | Black | Non-Hispanic | 1078 | 0 | 31.67 | Lung Disease | ||
15 | 2500 | 1295 | 63 | Female | Black | Non-Hispanic | 616 | 38 | 24.08 | ||
16 | 1201 | 56 | Male | White | Non-Hispanic | 518 | 0 | 33.47 | Lung Disease | ||
17 | 250 | 1363 | 61 | Male | White | Non-Hispanic | 729 | 36.7 | 33.73 | Other Cardiovascular Disease, Alcohol use, Substance Use Disorder | |
18 | 2500 | 609 | 58 | Male | White | Non-Hispanic | 720 | 0 | 35.89 | Other Cardiovascular Disease, Alcohol use | |
19 | 47.6 | 60 | Male | Black | Non-Hispanic | 786 | 99.7 | 47.9 | Advanced Liver Disease, Diabetes Mellitus, Heart Disease, Other Cardiovascular Disease, Lung Disease | ||
20 | 1020 | T-Cell Subset | 65 | Female | Black | Non-Hispanic | 539 | 0 | 27.44 | Advanced Liver Disease, History of Cancer, Smoking History, Substance Use Disorder | |
21 | 823 | 61 | Male | Black | Non-Hispanic | 746 | 0 | 29.42 | History of Cancer, Heart Disease, Substance Use Disorder | ||
22 | 343 | T-Cell Subset | 62 | Female | White | Hispanic | 706 | 50.6 | 30.21 | History of Cancer, Lung Disease, Smoking History | |
23 | 196 | T-Cell Subset | 58 | Female | White | Non-Hispanic | 1413 | 0 | 42.91 | Smoking History | |
24 | 1626 | 64 | Male | Black | Non-Hispanic | 612 | 0 | 38.72 | Advanced Liver Disease, History of Cancer, Active Cancer, Diabetes Mellitus | ||
25 | 2166 | 315 | T-Cell Subset | 60 | Female | Black | Non-Hispanic | 225 | 0 | 39.49 | Advanced Liver Disease, History of Cancer, Other Cardiovascular Disease, Alcohol Use |
26 | 159 | 56 | Female | Black | Non-Hispanic | 898 | 0 | 24.26 | Smoking history | ||
Median value | 2087 | 492 |